Circulating ACE+ EMPs during acute lung injury

What is it about?

Circulating endothelial microparticles (EMPs) are considered to be markers of endothelial injury, and lung microvascular endothelial cells express higher levels of angiotensin-converting enzyme (ACE). The aim of this study is to examine whether the number of ACE+ microvascular EMPs could be a prognostic marker for the development of acute respiratory distress syndrome (ARDS) in septic patients. The numbers of EMPs and ACE+ EMPs in the culture supernatant from human microvascular endothelial cells, as well as in the blood of mouse lung injury models and septic patients, were examined by flow cytometry. ACE+ EMPs in the culture supernatant from pulmonary microvascular endothelial cells increased after exposure to an inflammatory stimulus. In the mouse lung injury models, the circulating ACE+ EMPs and ACE+ EMP/EMP ratio were higher than in the controls (p < 0.001). The ACE+ EMP/EMP ratio was correlated with the wet-to-dry lung ratio (rs = 0.775, p < 0.001). The circulating ACE+ EMPs and ACE+ EMP/EMP ratio on admission were significantly increased in septic patients who developed ARDS compared with septic patients who did not (p < 0.001).

Featured Image

Why is it important?

Circulating ACE+ EMPs from pulmonary microvascular endothelial cells could be a marker for evaluating the injury of pulmonary microvascular endothelial cells and a prognostic marker for developing ARDS in septic patients.